Tai-Yue Announces Change in R&D Management
Tai-Yue announces a leadership change in its R&D department: Mr. Hsieh Yi-Huang, Deputy General Mana… · 2026-08-14
台耀 News Releases
[Taisyo] Board Approves 2nd Quarter Consolidated Financial Report for Fiscal Year 115
Taisyo's board of directors approved the 2nd quarter consolidated financial report for fiscal year 1… · 2026-08-13
[Tai-Yo] Board Approves Construction of Automated Smart Warehouse and GLP-1 Transportation System for Injectable Plant
Tai-Yo's board has approved an investment of NT$1.4 billion to build an automated smart warehouse an… · 2026-08-13
Taiya Corporation Invited to Participate in Institutional Briefing Hosted by KGI Securities
Taiya Corporation will attend an institutional investor briefing hosted by KGI Securities on August … · 2026-08-13
Formosa Laboratories Announces Q1 2026 Consolidated Financial Report
Formosa Laboratories' board of directors and audit committee approved the Q1 2026 consolidated finan… · 2026-05-14
Formosa Laboratories Announces Q1 2026 Consolidated Financial Report
Formosa Laboratories' board of directors and audit committee approved the Q1 2026 consolidated finan… · 2026-05-14
【Taiyao】Announcement of Shareholders' Meeting Resolution Approving the Release of Directors (Including Independent Directors) and Their Representatives from Non-Competition Restrictions
On June 24, 115, Taiyao's annual shareholders' meeting approved a resolution permitting certain dire… · 2026-06-24
[Tayyo] Announcement of Important Resolutions from the 115th Annual Shareholders' Meeting
Tayyo held its annual shareholders' meeting on June 24, 2026, approving the allocation of profits fo… · 2026-06-24
【Taiyao】February 2026 Monthly Revenue NT$233 Million (YoY -20.5%)
Taiyao Chemical, a major manufacturer of active pharmaceutical ingredients (APIs), announced its Feb… · 2026-02-01
[Formosa Laboratories] May 2026 Revenue Reaches NT$359 Million (YoY -4.9%)
Formosa Laboratories (Taiwan Stock Code: 4746) reported its monthly revenue for May 2026 at NT$358.6… · 2026-05-01
[TTY] Invitation to Investor Briefing hosted by KGI Securities
TTY Biopharm announced it will participate in an investor briefing hosted by KGI Securities on May 2… · 2026-05-22
[Formosa Laboratories] March 2026 Revenue NT$456M (YoY -6.0%)
Formosa Laboratories announced its monthly revenue for March 2026 was NT$456 million, a 6.0% decreas… · 2026-03-01
[Taiyao] Company Acquires Production Equipment, Cumulative Amount with Same Counterparty Exceeds NT$500 Million Within One Year
Taiyao Corporation announced the acquisition of sterile preparation production equipment and ancilla… · 2026-05-12
Taitron Reports April 2026 Revenue of 331 Million, Down 25.7% Year-over-Year
Taitron announced a challenging April 2026, with revenue falling to 330.541 billion JPY, a 25.7% dec… · 2026-04-01
【Taiyao】Announcement of Board Meeting Date for Q1 2026 Consolidated Financial Report
Taiyao announced the board meeting convocation notice on May 6, 2026, stating that a board meeting w… · 2026-05-06
[Formosa Laboratories] March 2026 Revenue NT$456M (YoY -6.0%)
Formosa Laboratories announced its monthly revenue for March 2026 was NT$456 million, a 6.0% decreas… · 2026-03-01
【Taiyao】February 2026 Monthly Revenue NT$233 Million (YoY -20.5%)
Taiyao Chemical, a major manufacturer of active pharmaceutical ingredients (APIs), announced its Feb… · 2026-02-01
Taitron Reports April 2026 Revenue of 331 Million, Down 25.7% Year-over-Year
Taitron announced a challenging April 2026, with revenue falling to 330.541 billion JPY, a 25.7% dec… · 2026-04-01
【Taiyao】Announcement of Board Meeting Date for Q1 2026 Consolidated Financial Report
Taiyao announced the board meeting convocation notice on May 6, 2026, stating that a board meeting w… · 2026-05-06
[Taiyao] Company Acquires Production Equipment, Cumulative Amount with Same Counterparty Exceeds NT$500 Million Within One Year
Taiyao Corporation announced the acquisition of sterile preparation production equipment and ancilla… · 2026-05-12